Compumedics

Compumedics EBITDA per Share

The EBITDA per Share of Compumedics (CMP.AX) as of Oct 18, 2026 is 0.01 AUD.

EBITDA per Share

0.01AUD

YoY

133.63%

Last updated:

EBITDA per Share of Compumedics is 2026 0.01 AUD. EBITDA per Share of Compumedics was 2025 0.00 AUD. It decreases by 133.63% higher compared to the previous year.

The Compumedics EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
0.03 AUD
Jan 1, 2020
-0.00 AUD
Jan 1, 2021
0.01 AUD
Jan 1, 2022
0.00 AUD
Jan 1, 2023
-0.03 AUD
Jan 1, 2024
0.01 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.01 AUD
The Compumedics EBITDA per Share history
YEAREBITDA per ShareYoY
0.01AUD+133.63%
0.00AUD-45.56%
0.01AUD-119.17%
-0.03AUD-1,227.70%
0.00AUD-51.36%
0.01AUD-246.30%
-0.00AUD-115.09%
0.03AUD+49.42%
0.02AUD+113.85%
0.01AUD-37.72%
0.01AUD-10.41%
0.02AUD+81.14%
0.01AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

EBITDA per Share of Compumedics is 0.01 AUD in 2026.

On Eulerpool you can find the complete historical development of EBITDA per Share Compumedics since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Compumedics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Compumedics